CuraCell TX

CuraCell is a biotechnology company and contract development and manufacturing organization (CDMO) specializing in the development of next-generation, off-the-shelf cell therapies. The company leverages a proprietary induced pluripotent stem cell (iPSC) platform to engineer universal donor cells that can be differentiated into various therapeutic cell types, including T cells and NK cells. By focusing on scalable manufacturing and standardized cell products, CuraCell aims to overcome the limitations of patient-specific autologous therapies, such as high costs and complex logistics. Their business model combines internal therapeutic programs with strategic CDMO services to support the broader cell therapy industry in accelerating clinical development.